<SEC-DOCUMENT>0001178913-16-005455.txt : 20160517
<SEC-HEADER>0001178913-16-005455.hdr.sgml : 20160517
<ACCEPTANCE-DATETIME>20160517073910
ACCESSION NUMBER:		0001178913-16-005455
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20160517
FILED AS OF DATE:		20160517
DATE AS OF CHANGE:		20160517

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Check-Cap Ltd
		CENTRAL INDEX KEY:			0001610590
		STANDARD INDUSTRIAL CLASSIFICATION:	X-RAY APPARATUS & TUBES & RELATED IRRADIATION APPARATUS [3844]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			L3

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36848
		FILM NUMBER:		161656099

	BUSINESS ADDRESS:	
		STREET 1:		ABBA HUSHI AVENUE P.O. BOX 1271
		CITY:			ISFIYA
		STATE:			L3
		ZIP:			30090
		BUSINESS PHONE:		972-4-8303400

	MAIL ADDRESS:	
		STREET 1:		ABBA HUSHI AVENUE P.O. BOX 1271
		CITY:			ISFIYA
		STATE:			L3
		ZIP:			30090
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>zk1618523.htm
<DESCRIPTION>6-K
<TEXT>
<html>
<head>
<title></title>
<!--Licensed to: ZKG
    Document created using EDGARfilings PROfile 4.0.0.0
    Copyright 1995 - 2016 Summit Financial Printing, LLC.  All rights reserved.-->
</head>
<body style="FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt" bgcolor="#ffffff" text="#000000">
<div>
<hr style="BORDER-BOTTOM: black 1px solid; TEXT-ALIGN: center; BACKGROUND-COLOR: #ffffff; HEIGHT: 10px; COLOR: #ffffff; MARGIN-LEFT: auto; BORDER-TOP: black 4px solid; MARGIN-RIGHT: auto">
</div>

<div>&#160;</div>

<div>
<div id="DSPFPageHeader"></div>

<div style="TEXT-ALIGN: center; FONT: bold 14pt/15.95pt 'Times New Roman', Times, serif">UNITED STATES</div>

<div style="TEXT-ALIGN: center; FONT: bold 14pt/15.95pt 'Times New Roman', Times, serif">SECURITIES AND EXCHANGE COMMISSION</div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 13.7pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">WASHINGTON, DC 20549</div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 13.7pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">&#160;</div>

<div style="TEXT-ALIGN: center; FONT: bold 14pt/13.7pt 'Times New Roman', Times, serif">FORM 6-K</div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 13.7pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">&#160;</div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 13.7pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">REPORT OF FOREIGN PRIVATE ISSUER</div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 13.7pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">PURSUANT TO RULE 13a-16 OR 15d-16 UNDER</div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 13.7pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">THE SECURITIES EXCHANGE ACT OF 1934</div>

<div style="LINE-HEIGHT: 13.7pt"><br style="LINE-HEIGHT: 13.7pt">
</div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 13.7pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">For May 2016</div>

<div style="LINE-HEIGHT: 13.7pt; FONT-WEIGHT: bold"><br style="LINE-HEIGHT: 13.7pt">
</div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 13.7pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Commission File No. 001-36848</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 13.7pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">&#160;

<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 16pt; FONT-WEIGHT: bold">Check-Cap Ltd. </font>

<div>
<hr style="TEXT-ALIGN: center; BACKGROUND-COLOR: #000000; HEIGHT: 2px; COLOR: #000000; MARGIN-LEFT: auto; MARGIN-RIGHT: auto" noshade="noshade">
</div>
</div>

<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; FONT-FAMILY: times new roman; MARGIN-LEFT: 0pt; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-RIGHT: 0pt">Check-Cap Building</div>

<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; FONT-FAMILY: times new roman; MARGIN-LEFT: 0pt; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-RIGHT: 0pt">Abba Hushi Avenue</div>

<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; FONT-FAMILY: times new roman; MARGIN-LEFT: 0pt; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-RIGHT: 0pt">P.O. Box 1271</div>

<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; FONT-FAMILY: times new roman; MARGIN-LEFT: 0pt; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-RIGHT: 0pt">Isfiya, 30090</div>

<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; FONT-FAMILY: times new roman; MARGIN-LEFT: 0pt; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-RIGHT: 0pt">Mount Carmel, Israel</div>

<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; FONT-FAMILY: times new roman; MARGIN-LEFT: 0pt; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-RIGHT: 0pt">&#160;</div>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 13.7pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 13.7pt; TEXT-INDENT: 155pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">&#160;</div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 13.7pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">Form 20-F &#9746;<font style="WIDTH: 9pt; DISPLAY: inline-block; FONT-SIZE: 1px" id="TRGRRTFtoHTMLTab">&#160;</font>Form 40-F &#9744;</div>

<div style="LINE-HEIGHT: 13.7pt"><br style="LINE-HEIGHT: 13.7pt">
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 13.7pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ____</div>

<div style="LINE-HEIGHT: 13.7pt"><br style="LINE-HEIGHT: 13.7pt">
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 13.7pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ____</div>

<div style="LINE-HEIGHT: 13.7pt"><br style="LINE-HEIGHT: 13.7pt">
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 13.7pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">Indicate by check mark whether the registrant by furnishing the information contained in this form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 13.7pt; TEXT-INDENT: 175pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">&#160;</div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 13.7pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">Yes &#9744;<font style="WIDTH: 9pt; DISPLAY: inline-block; FONT-SIZE: 1px" id="TRGRRTFtoHTMLTab">&#160;</font>No&#9746;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 13.7pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 13.7pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">If &#8220;Yes&#8221; marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82-___</div>

<div style="LINE-HEIGHT: 13.7pt"><br style="LINE-HEIGHT: 13.7pt">
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 13.7pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">This Form 6-K is being incorporated by reference into the Registrant&#8217;s Form S-8 Registration Statement File No. 333-203384.</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 13.7pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">&#160;</div>

<div style="MARGIN-TOP: 10pt; MARGIN-BOTTOM: 10pt; CLEAR: both" id="DSPFPageBreakArea">
<div style="PAGE-BREAK-AFTER: always" id="DSPFPageBreak">
<hr style="BORDER-RIGHT-WIDTH: 0px; BACKGROUND-COLOR: #000000; MARGIN: 4px 0px; WIDTH: 100%; BORDER-TOP-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; HEIGHT: 2px; COLOR: #000000; CLEAR: both; BORDER-LEFT-WIDTH: 0px" noshade="noshade">
</div>
</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 13.7pt; TEXT-INDENT: 24pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">On May 17, 2016, Check-Cap Ltd. (the &#8220;Company&#8221;) announced that a podium presentation entitled &#8220;A Novel Preparation-Free X-Ray Imaging Capsule for Colon Cancer Screening&#8221; will be delivered at Digestive Disease Week&#174; (DDW) 2016. The conference is taking place in San Diego from May 21-24.</div>

<div style="LINE-HEIGHT: 13.7pt"><br style="LINE-HEIGHT: 13.7pt">
</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 13.7pt; TEXT-INDENT: 24pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">Prof. Nadir Arber, M.D., Director of the Integrated Cancer Prevention Center (ICPC) at Tel Aviv Sourasky Medical Center, and a leading investigator in the Company's multicenter study, will present on May 21 from 10:45 a.m. &#8211; 11:00 a.m. in room 31A.</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 13.7pt"><br style="LINE-HEIGHT: 13.7pt">
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 13.7pt; TEXT-INDENT: 24pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">A copy of the press release is attached as Exhibit 99.1 and is incorporated by reference herein.</div>

<div style="LINE-HEIGHT: 13.7pt">&#160;</div>

<div style="MARGIN-TOP: 10pt; MARGIN-BOTTOM: 10pt; CLEAR: both" id="DSPFPageBreakArea">
<div style="PAGE-BREAK-AFTER: always" id="DSPFPageBreak">
<hr style="BORDER-RIGHT-WIDTH: 0px; BACKGROUND-COLOR: #000000; MARGIN: 4px 0px; WIDTH: 100%; BORDER-TOP-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; HEIGHT: 2px; COLOR: #000000; CLEAR: both; BORDER-LEFT-WIDTH: 0px" noshade="noshade">
</div>
</div>

<div style="LINE-HEIGHT: 13.7pt; FONT-WEIGHT: bold">Exhibits</div>

<div style="LINE-HEIGHT: 13.7pt"><br style="LINE-HEIGHT: 13.7pt">
</div>

<table style="WIDTH: 100%; BORDER-COLLAPSE: collapse; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt" id="57813da80d9a411cb8c8945f034aef6b" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 10.03%; VERTICAL-ALIGN: top">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 13.7pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">99.1</div>
</td>
<td style="WIDTH: 89.97%; VERTICAL-ALIGN: top">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 13.7pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">Press release, dated May 17, 2016.</div>
</td>
</tr>
</table>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 13.7pt; MARGIN-TOP: 12pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">&#160;</div>

<div style="MARGIN-TOP: 10pt; MARGIN-BOTTOM: 10pt; CLEAR: both" id="DSPFPageBreakArea">
<div style="PAGE-BREAK-AFTER: always" id="DSPFPageBreak">
<hr style="BORDER-RIGHT-WIDTH: 0px; BACKGROUND-COLOR: #000000; MARGIN: 4px 0px; WIDTH: 100%; BORDER-TOP-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; HEIGHT: 2px; COLOR: #000000; CLEAR: both; BORDER-LEFT-WIDTH: 0px" noshade="noshade">
</div>
</div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 13.7pt; MARGIN-TOP: 12pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">SIGNATURE</div>

<div style="LINE-HEIGHT: 13.7pt">&#160;</div>

<div style="LINE-HEIGHT: 13.7pt">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 13.7pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 13.7pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">
<table style="WIDTH: 100%; BORDER-COLLAPSE: separate; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt" id="1ec4559c508b437a91c93defe01e1637" border="0" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 50%" valign="top">&#160;</td>
<td style="WIDTH: 38%; FONT-FAMILY: 'Times New Roman', Times, serif" valign="top" colspan="2">
<div style="FONT-WEIGHT: bold">Check-Cap Ltd.</div>
</td>
<td style="WIDTH: 12%" valign="top">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 50%" valign="top">&#160;</td>
<td style="WIDTH: 3%" valign="top">&#160;</td>
<td style="WIDTH: 35%" valign="top">&#160;</td>
<td style="WIDTH: 12%" valign="top">&#160;</td>
</tr>

<tr>
<td style="PADDING-BOTTOM: 2px; WIDTH: 50%" valign="top" align="left">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">&#160;</div>
</td>
<td style="PADDING-BOTTOM: 2px; WIDTH: 3%" valign="top">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">By: </div>
</td>
<td style="BORDER-BOTTOM: #000000 2px solid; WIDTH: 35%" valign="top" nowrap="nowrap" align="left">/s/&#160;Lior Torem</td>
<td style="PADDING-BOTTOM: 2px; WIDTH: 12%" valign="top">&#160;</td>
</tr>

<tr style="HEIGHT: 11px">
<td style="WIDTH: 50%" valign="top">&#160;</td>
<td style="WIDTH: 3%" valign="top">&#160;</td>
<td style="WIDTH: 35%" valign="bottom" nowrap="nowrap" align="left">Name: Lior Torem</td>
<td style="WIDTH: 12%" valign="top">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 50%" valign="top">&#160;</td>
<td style="WIDTH: 3%" valign="top">&#160;</td>
<td style="WIDTH: 35%" valign="top">Title: Chief Financial Officer&#160;&#160;&#160;</td>
<td style="WIDTH: 12%" valign="top">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 50%" valign="top">&#160;</td>
<td style="WIDTH: 3%" valign="top">&#160;</td>
<td style="WIDTH: 35%" valign="top">&#160;</td>
<td style="WIDTH: 12%" valign="top">&#160;</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 13.7pt">Dated: May 17, 2016</div>

<div style="LINE-HEIGHT: 13.7pt">&#160;</div>

<div style="LINE-HEIGHT: 13.7pt">
<hr style="BORDER-BOTTOM: black 4px solid; TEXT-ALIGN: center; BACKGROUND-COLOR: #ffffff; HEIGHT: 10px; COLOR: #ffffff; MARGIN-LEFT: auto; BORDER-TOP: black 1px solid; MARGIN-RIGHT: auto">
<br style="LINE-HEIGHT: 13.7pt">
</div>
</div>

<div>&#160;</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>exhibit_99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<html>
<head>
<title></title>
<!--Licensed to: ZKG
    Document created using EDGARfilings PROfile 4.0.0.0
    Copyright 1995 - 2016 Summit Financial Printing, LLC.  All rights reserved.-->
</head>
<body style="FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt" bgcolor="#ffffff" text="#000000">
<div>
<hr style="BORDER-BOTTOM: black 1px solid; TEXT-ALIGN: center; BACKGROUND-COLOR: #ffffff; HEIGHT: 10px; COLOR: #ffffff; MARGIN-LEFT: auto; BORDER-TOP: black 4px solid; MARGIN-RIGHT: auto">
</div>

<div>&#160;</div>

<div>
<div style="TEXT-ALIGN: right; FONT: bold 10pt/13.7pt 'Times New Roman', Times, serif"><u>Exhibit 99.1</u></div>

<div style="LINE-HEIGHT: 13.7pt; MARGIN-TOP: 12pt"><br style="LINE-HEIGHT: 13.7pt">
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 13.7pt"><img style="WIDTH: 170px; HEIGHT: 72px" src="image0.jpg"></div>

<div style="LINE-HEIGHT: 13.7pt"><br style="LINE-HEIGHT: 13.7pt">
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 13.7pt">&#160;</div>

<div style="TEXT-ALIGN: center; FONT: bold 12pt/13.7pt 'Times New Roman', Times, serif">Check-Cap Announces Presentation Evaluating Ingestible Capsule </div>

<div style="TEXT-ALIGN: center; FONT: bold 12pt/13.7pt 'Times New Roman', Times, serif">for Preparation-Free Colorectal Cancer Screening at </div>

<div style="TEXT-ALIGN: center; FONT: bold 12pt/13.7pt 'Times New Roman', Times, serif">Digestive Disease Week&#174; 2016</div>

<div style="LINE-HEIGHT: 13.7pt"><br style="LINE-HEIGHT: 13.7pt">
</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 13.7pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">ISFIYA, Israel, and BOSTON, May 17, 2016 - Check-Cap Ltd. (the &#8220;Company&#8221; or &#8220;Check-Cap&#8221;) (NASDAQ: CHEK, CHEKW), a clinical stage medical diagnostics company engaged in the development of an ingestible capsule for preparation-free, colorectal cancer screening, today announced a podium presentation entitled &#8220;A Novel Preparation-Free X-Ray Imaging Capsule for Colon Cancer Screening&#8221; will be delivered at Digestive Disease Week&#174; (DDW) 2016. The conference is taking place in San Diego from May 21-24.</div>

<div style="LINE-HEIGHT: 13.7pt"><br style="LINE-HEIGHT: 13.7pt">
</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 13.7pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt"><font style="FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">Prof.</font> Nadir Arber, M.D., Director of the Integrated Cancer Prevention Center (ICPC) at Tel Aviv Sourasky Medical Center, <font style="FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">and a leading investigator in the Company's multicenter study</font>, will present on May 21 from 10:45 a.m. &#8211; 11:00 a.m. in room 31A.</div>

<div style="LINE-HEIGHT: 13.7pt"><br style="LINE-HEIGHT: 13.7pt">
</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 13.7pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">About Check-Cap</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 13.7pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 13.7pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">Check-Cap is a clinical stage company developing the world&#8217;s first diagnostic system for preparation-free examination of the colon to identify precancerous polyps and cancers.</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 13.7pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 13.7pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">Utilizing proprietary, ultra-low-dose x-ray technology, the system scans the colon in its natural state and creates three-dimensional images of the inner surface. Without requiring traditional bowel cleansing or modifications to a person's diet and activities, Check-Cap's system is designed to address the most significant barriers to colonoscopy and increase adherence with colorectal cancer screening recommendations. The Check-Cap system is currently not cleared for marketing in any jurisdiction.</div>

<div style="LINE-HEIGHT: 13.7pt"><br style="LINE-HEIGHT: 13.7pt">
</div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 13.7pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt"># # #</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 13.7pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">CONTACT:</div>

<div style="TEXT-ALIGN: left; FONT: 10pt/13.7pt 'Times New Roman', Times, serif"><u>Investors</u></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 13.7pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">David Carey</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 13.7pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">Lazar Partners Ltd.</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 13.7pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">212-867-1768</div>

<div style="TEXT-ALIGN: left; FONT: 10pt/13.7pt 'Times New Roman', Times, serif"><u>dcarey@lazarpartners.com</u></div>

<div style="LINE-HEIGHT: 13.7pt"><br style="LINE-HEIGHT: 13.7pt">
</div>

<div style="TEXT-ALIGN: left; FONT: 10pt/13.7pt 'Times New Roman', Times, serif"><u>Media</u></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 13.7pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">Rob Sawyer</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 13.7pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">Lazar Partners Ltd.</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 13.7pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">212-843-0209</div>

<div style="TEXT-ALIGN: left; FONT: 10pt/13.7pt 'Times New Roman', Times, serif"><u>rsawyer@lazarpartners.com</u></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 13.7pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 13.7pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">
<hr style="BORDER-BOTTOM: black 4px solid; TEXT-ALIGN: center; BACKGROUND-COLOR: #ffffff; HEIGHT: 10px; COLOR: #ffffff; MARGIN-LEFT: auto; BORDER-TOP: black 1px solid; MARGIN-RIGHT: auto">
</div>

<div id="DSPFPageFooter">
<div style="LINE-HEIGHT: 11.4pt"><br style="LINE-HEIGHT: 11.4pt">
</div>

<div style="LINE-HEIGHT: 11.4pt"><br style="LINE-HEIGHT: 11.4pt">
</div>
</div>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>image0.jpg
<TEXT>
begin 644 image0.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !) *L# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#W^BBN&^(G
MQ&M/!-DL,2K<ZM.N88">$']]_;V[U48.;Y8B;25V=;J6JZ?H]HUUJ-Y!:P#J
M\SA1^O6N#U#XW^$+.1D@DO+TC^*"#"G\6(KYZUO7M4\1W[7NK7DES,3QN/RH
M/15Z ?2LVO1A@8V]]G++$/[)]#_\+]\.?] W4_\ OA/_ (JC_A?OAS_H&ZG_
M -\)_P#%5\\45I]2I$>WF?0__"_?#G_0-U/_ +X3_P"*H_X7[X<_Z!NI_P#?
M"?\ Q5?/%%'U*D'UB9]#_P#"_?#G_0-U/_OA/_BJ/^%^^'/^@;J?_?*?_%5\
M\44?4J0?6)GT/_POWPY_T#=3_P"^$_\ BJ/^%^^'/^@;J?\ WPG_ ,57SQ11
M]2I!]8F?0_\ POWPY_T#=3_[Y3_XJC_A?OAS_H&ZG_WPG_Q5?/%'4X )/H*/
MJ5(/;S/H_3_C=HVJ:A!86.C:M/=3L$CC5$R3_P!]=/>O3E)*@L-I(Y'I7G'P
MG^'R^%]*75-1B']L7:9(8<V\9Y"#W/?\NU=CJ>H')MX6]G8?R%>;6Y%*T-CK
MAS6O(LS:M;Q2%,,^.I7I2+K-L3R)%^HK!HK$LZF&XBG&8I%;Z5+7)*S(P9&*
ML.A!K;T_4O.(AFP).S?WO_KTP-*BBB@#-\0:U;^'M!O=6NC^ZMHBY'=CV4>Y
M.!^-?(&LZO>:]K%UJE_(7N;AR['LH[*/8#@5[C\?M6:#0-,TI&Q]KG,L@]50
M<?JP_*O *]3!4TH<_<X\1.[Y3M/!7@0>([>;4]1NS9Z5 2#(, N1UP3P .YK
M0U[PCX0'A^^U#P_KIGN+--[0F57WC('H#WZ\U>O4EE^ ]E]A!,:2@W03T#MG
M/MG;FO+T1Y YC1FVJ6;:,X7N3[5I#GJ2<N:UGL)VBDK'6^*_"MCH?AO0M1M9
M9WFU"/=*LC J#M!XP/>BT\+6,_PSO?$C2SB\@F,:H&'ED;E'(QGN>]>@ZK/X
M7@\&^&SXGMY9HS;+Y C#'!V+G."/:J>L2Z%-\']5?P[#)#8>:!MD!!W[USU)
M]JR5:=DM=]_F5[-7;\C-;P-X,T_1=,O=9U>\M&O85=?F&"VT$@84^M<P_ABR
MUCQDFC^%[QKJS9%<W,O\ Q\Y/ Z?2O0]=O?#-GX3\-GQ)837:-;+Y CS\IV+
MG/(]JS_AU<:/<^,M<DT*W:VMVLT^S1R?>7!^;N>^.]*-2:BYZ_H-PBVD12>
M/ MK.-,NO$;IJ7"G=,BX;_=Q@?0FL#3/!-A<:3XIN+BYG:;1W=(6C("OM!.6
M&#Z=C7&7J3QZA<1W:L+H2L)0_P![?GG/XUZA\,C!:^%/$IU.)_L\;J;B-A\V
MT(<@BM)\].'-S7V(CRRE:UCG-0\(V&B^ ;;5]2EN%U6](^SVZL H!Y!88SPO
M)^HKBZ].^+]G=37.F:M'*)M*DA$<.S[L;'G_ ,>&,?3%>8UM0DY0YF]R*J2E
M9!7I_P &/!HUW7VUF]CW6&G,"@8<23=0/HO7ZXKS*.-YI4BB4O([!44=22<
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MY5OP(%?(.H6%UI6HW%A>Q&*YMY#'(A[$?TK[6KSCXF?#./Q?#_:.G;(=9B7
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8** *\%E!;<QQC=_>/)JQ110 4444 ?_9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
